Dow Jones futures are pointing to a strong start today, April 8. A gap-up opening means stocks are likely to open higher than they closed yesterday. That’s a big deal in the world of trading.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
We from the media firmly believe that every large‑scale financial policy deserves a plain explanation. Here, we dive into Trump’s newly announced plan for a “stimulus check 2025”, his proposal to give $2,000 payments to Americans funded by tariff revenues. With inflation still weighing on household budgets and the economy facing multiple pressures, the move is…
On January 26, 2026, Meta, TikTok and YouTube were ordered to stand trial in a U.S. courtroom over claims their apps hurt young people’s mental health. This case is unusual. It is one of the first times major tech firms must defend their platform design in court, not just their content rules. Continue Reading on…
Festival Foods, a well-known grocery chain in Wisconsin, is being bought by Schnuck Markets of St. Louis. The deal covers 42 Festival Foods stores plus nine from Hometown Grocers. It will be run under a new parent, the 1939 Group, while keeping the Festival Foods brand, store names, and many of its current staff. We…
Gold has been climbing fast in early 2026. On 22 January 2026, gold prices reached new record highs, with spot gold crossing above $4,900 per ounce. Analysts are now talking about a rare milestone, $5,000 an ounce or more. This jump is not random. It comes as strong demand from big banks, investors and safe-haven…
The Australian Securities Exchange (ASX) posted a strong performance this week, driven by powerful gains in precious metals such as gold and silver, coupled with renewed strength in the financials sector. Continue Reading on Meyka This article is available in full on our main platform. Get access to complete analysis, stock insights, and more. Read…
Earnings spotlight on 4506.T stock after hours; Sumitomo Pharma at JPY 2349.50 ahead of 30 Jan 2026 results